Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
165
Share
QR code
Edit Profile
Stephen Staal
Professor
MD-HEMATOLOGY-ONCOLOGY | COLLEGE-MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Publications
Network
Websites
Contact
All
Research
Publications
Network
Websites
Contact
Research Terms & Keywords
Research Terms
Hematology
Research Projects
Ends
Title
02-2025
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alpha-2b for Resected High-Risk Melanoma
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alpha-2b for Resected High-Risk Melanoma
NATL INST OF HLTH NC
08-2021
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival i
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival i
NATL SURG ADJUV BREAST & BOWE
09-2020
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
ECOGACRIN CANCER RESEARCH GROUP
09-2020
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
NATL INST OF HLTH NC
04-2020
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy versus High Dose Interferon a-2b for Resected High Risk Melanoma
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy versus High Dose Interferon a-2b for Resected High Risk Melanoma
EASTERN COOP ONCOLOGY GROU
04-2020
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy versus High Dose Interferon a-2b for Resected High Risk Melanoma
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy versus High Dose Interferon a-2b for Resected High Risk Melanoma
NATL INST OF HLTH NC
05-2019
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial assigning individualized Options for Treatment: The TAILORx Trial
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial assigning individualized Options for Treatment: The TAILORx Trial
EASTERN COOP ONCOLOGY GROU
05-2019
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial assigning individualized Options for Treatment: The TAILORx Trial
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial assigning individualized Options for Treatment: The TAILORx Trial
NATL INST OF HLT
04-2019
A Phase III Clinical Trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
A Phase III Clinical Trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
GENENTECH IN
04-2019
A Phase III Clinical Trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
A Phase III Clinical Trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
NATL SURG ADJUV BREAST & BOWE
02-2019
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
INC RESEARCH IN
02-2019
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
STEMLINE THERAPEUTICS, INC
10-2016
MK-3475-006-01
MK-3475-006-01
Merck Sharp & Dohme
05-2016
A Randomized Phase II study of MK-3475 versus chemothereapy in Patients with Advanced Melanoma
A Randomized Phase II study of MK-3475 versus chemothereapy in Patients with Advanced Melanoma
Merck Sharp & Dohme
02-2016
MK-3475-030-00
MK-3475-030-00
IDIS LTD
11-2015
MK-8669-064
MK-8669-064
Merck Sharp & Dohme
04-2015
A5481023
A5481023
PAREXEL INTERNATIONAL COR
02-2015
E3805: CHAARTED: ChemoHormonal Therapy versus Androgen
E3805: CHAARTED: ChemoHormonal Therapy versus Androgen
EASTERN COOP ONCOLOGY GROU
05-2011
FB-6/VEG110264
FB-6/VEG110264
NATL SURG ADJUV BREAST & BOWE
Publications
OpenAlex
Search Engines
No records were found when searching publication data for this expert. See our
OpenAlex FAQ
for more about this data.
Search Google Scholar for Stephen Staal
Co-Investigator Network
Inactive Expert
David Tran
Chief, Co-Director and Professor
University of Florida
Md-Neuroscience, College-Medicine
Expertnet Author Network
Experts within Florida Expertnet that have co-authored works with Stephen Staal.
Inactive Expert
Stephen Grobmyer
University of Florida
Eg-Biomedical, College-Engineering
Works Co-Authored: 53
Inactive Expert
Qizhi Zhang
Research Assistant Scientist
University of Florida
Eg-Biomedical, College-Engineering
Works Co-Authored: 45
Inactive Expert
Xiaoping Liang
Associate In
University of Florida
Eg-Biomedical, College-Engineering
Works Co-Authored: 12
Thomas George
Associateprofessor - Physician
University of Florida
Md-Hematology/Oncology, College-Medicine
tgeorge@ufl.edu
Works Co-Authored: 618
Merry Markham
Clinical Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
merry.markham@medicine.ufl.edu
Works Co-Authored: 156
Karen Daily Weinstein
Clinical Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
karen.daily@medicine.ufl.edu
Works Co-Authored: 81
Coy Heldermon
Associate Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
coy.heldermon@medicine.ufl.edu
Works Co-Authored: 97
Inactive Expert
Bruce Stechmiller
Clinical Associate Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
Works Co-Authored: 3
Frederic Kaye
Professor
University of Florida
Md-Molecular Gentcs - Microbio, College-Medicine
fkaye@ufl.edu
Works Co-Authored: 212
Julia Close
Designated Institutional Official (Dio) & Associate Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
jclose@ufl.edu
Works Co-Authored: 37
Ryan Thomas
Associate Professor (Tenured)
University of Florida
Md-Surgery-Surgonc-Pbs, College-Medicine
ryan.thomas.md@ufl.edu
Works Co-Authored: 180
Inactive Expert
David Tran
Chief, Co-Director and Professor
University of Florida
Md-Neuroscience, College-Medicine
Works Co-Authored: 44
Hans Ghayee
Professor; Va Section Chief
University of Florida
Md-Endocrinology, College-Medicine
hans.ghayee@medicine.ufl.edu
Works Co-Authored: 110
Dennie Jones
Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
dvjonesii@ufl.edu
Works Co-Authored: 92
Ji-Hyun Lee
Professor & Associate Director For Cancer Quantitative Sciences
University of Florida
Phhp-Com Biostatistics, Phhp-Com Integrated Programs
jihyun.lee@ufl.edu
Works Co-Authored: 1043
Jonathan Chatzkel
Assistant Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
jonathanchatzkel@ufl.edu
Works Co-Authored: 33
Brian Ramnaraign
Assistant Professor
University of Florida
Md-Urology, College-Medicine
ramnaraign85@ufl.edu
Works Co-Authored: 68
Ashley Ghiaseddin
Clinical Associate Professor
University of Florida
Md-Neurological Surgery, College-Medicine
ashley.ghiaseddin@neurosurgery.ufl.edu
Works Co-Authored: 71
Inactive Expert
Sherise Rogers
Assistant Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
Works Co-Authored: 67
Inactive Expert
Jesus Fabregas Mercado
Ast Prof
University of Florida
Md-Hematology-Oncology, College-Medicine
Works Co-Authored: 35
Inactive Expert
Martina Murphy
Senior Associate Dean For Gme, Dio
University of Florida
Md-Hematology-Oncology, College-Medicine
Works Co-Authored: 33
Inactive Expert
David DeRemer
Clinical Professor
University of Florida
Ph-Pharmtherapy Trnsl Rsch, College-Pharmacy
Works Co-Authored: 49
Huabei Jiang
Professor
University of South Florida
Medical Engineering, College Of Engineering
hjiang1@usf.edu
Works Co-Authored: 216
Inactive Expert
Peter Hosein
University of Miami
Medicine, Medical
Works Co-Authored: 89
Websites
Search Google Scholar for Stephen Staal
Contact Information
stephen.staal@medicine.ufl.edu
3522737832
PO Box 100278 GAINESVILLE, FL 32610-0278
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
